An Evaluation of the Cost-Effectiveness of Reslizumab in Poorly Controlled Eosinophilic Asthma

May 1, 2018, 00:00
10.1016/j.jval.2018.04.1592
https://www.valueinhealthjournal.com/article/S1098-3015(18)31898-9/fulltext
Title : An Evaluation of the Cost-Effectiveness of Reslizumab in Poorly Controlled Eosinophilic Asthma
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31898-9&doi=10.1016/j.jval.2018.04.1592
First page :
Section Title :
Open access? : No
Section Order : 825
Categories :
Tags :
Regions :
ViH Article Tags :